Gene · 6624
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinoma. | Cancer Sci | 2023 | 37565582 | PubTator, text mining | PubMed |
| Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. | Int J Biol Sci | 2023 | 37564197 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma. | Oncol Lett | 2023 | 37559574 | PubTator, text mining | PubMed |
| The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion. | Cell Death Dis | 2023 | 37550301 | PubTator, text mining | PubMed |
| Human retinal secretome: A cross-link between mesenchymal and retinal cells. | World J Stem Cells | 2023 | 37545752 | PubTator, text mining | PubMed |
| System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma. | PLoS One | 2023 | 37535572 | PubTator, text mining | PubMed |
| Comprehensive analysis of resistance mechanisms to EGFR-TKIs and establishment and validation of prognostic model. | J Cancer Res Clin Oncol | 2023 | 37532906 | PubTator, text mining | PubMed |
| Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC. | Discov Oncol | 2023 | 37526759 | PubTator, text mining | PubMed |
| Micromorphological observation of HLE cells under knockdown of Fascin using LV-SEM. | Med Mol Morphol | 2023 | 37526656 | PubTator, text mining | PubMed |
| The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle. | PLoS Pathog | 2023 | 37523412 | PubTator, text mining | PubMed |
| FSCN1 has a potential indication for the prognosis and regulates the migration of HNSCC. | Cancer Biomark | 2023 | 37522194 | PubTator, text mining | PubMed |
| Preparation of chitosan-coated hollow tin dioxide nanoparticles and their application in improving the oral bioavailability of febuxostat. | Int J Pharm X | 2023 | 37521247 | PubTator, text mining | PubMed |
| Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells. | Mol Oncol | 2023 | 37518985 | PubTator, text mining | PubMed |
| Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights. | Int J Mol Sci | 2023 | 37511011 | PubTator, text mining | PubMed |
| Roles of Fascin in Dendritic Cells. | Cancers (Basel) | 2023 | 37509352 | PubTator, text mining | PubMed |
| MicroRNA (miR)-124: A Promising Therapeutic Gateway for Oncology. | Biology (Basel) | 2023 | 37508353 | PubTator, text mining | PubMed |
| Myosin-5 varies its steps along the irregular F-actin track. | bioRxiv | 2023 | 37503193 | PubTator, text mining | PubMed |
| An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma. | NAR Cancer | 2023 | 37492374 | PubTator, text mining | PubMed |
| FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma. | BMC Oral Health | 2023 | 37491232 | PubTator, text mining | PubMed |
| Case report: Hepatic inflammatory pseudotumor-like follicular dendritic cell sarcoma: a rare case and review of the literature. | Front Med (Lausanne) | 2023 | 37476617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6624/papers?page=14